Selvin Sundar RajMani IndiaAssociate Professor in Nephrology, Christian Medical College, Vellore, India

Selvin Sundar Raj is a consultant Nephrologist, working as Associate Professor at Christian Medical College, Vellore, India. His research interests include glomerular diseases especially IgA nephropathy, Obstetric Nephrology and Mineral and Bone disorders post Kidney transplant. His recent publications include Maternal, Fetal, and Kidney Outcomes of Viable Pregnancies in Women with Underlying Kidney Disease: Experience from a Single Tertiary Care Center in India and Comprehensive evaluation of bone health among kidney transplant recipients – A prospective, single centre, observational cohort study from India. He is the Site Co-investigator for phase 2 and phase 3 multi-centre randomised clinical trials on IgA nephropathy and Lupus nephritis.

Upload Picture

https://storage.unitedwebnetwork.com/files/1099/4f8712fa93f3e9e68355ba2f1a63d891.jpeg

First name

Selvin Sundar Raj

Last name

Mani

Institution

Country

India

Sunday, February 9, 2025

Time	Session

9 a.m. 10:30 a.m.	HIT! High Impact Clinical Trials – Why and How HIT2 DavidWheeler Chair United KingdomUniversity College London Winston Wing ShingFung Chair Hong Kong, ChinaPrince of Wales Hospital, Hong Kong What Have We Learned From CONVINCE? HIT2-1 PeterBlankestijn Oral Abstract Presenter NetherlandsUniversity Medical Center Utrecht Design of the ZEUS Trial: Interleukin-6 Inhibition With Ziltivekimab for Cardiovascular Protection in Chronic Kidney Disease HIT2-2 VladoPerkovic Oral Abstract Presenter AustraliaUniversity of New South Wales, Sydney, Australia A Phase 1/2 Trial of Zigakibart in IgA Nephropathy (IgAN) HIT2-3 Jonathan Barret Oral Abstract Presenter jb81@leicester.ac.ukUnited KingdomUniversity of Leicester, Leicester, UK Observational Cohort With Embedded Randomized Controlled Trials to Study Pregnancy-Associated Progression of Renal Disease: A Feasibility Study of Dietary Nitrate (Beetroot Juice) to Protect Kidney Function in Pregnant Women With Chronic Kidney Disease HIT2-4 KateBramham Oral Abstract Presenter United KingdomKing's College London Design of Randomized Embedded Adaptive Platform Clinical Trial in South Asian Kidney Biopsy-Proven Primary Glomerular Diseases: Multi-Center, Multi-Arm and Multi-Stage HIT2-5 Selvin Sundar RajMani Oral Abstract Presenter IndiaAssociate Professor in Nephrology, Christian Medical College, Vellore, India SuceenaAlexander Oral Abstract Presenter IndiaChristian Medical College Vellore Brahmkamal Hall - Plenary Hall

Time

Session

9 a.m.

10:30 a.m.

HIT! High Impact Clinical Trials – Why and How

DavidWheeler Chair United KingdomUniversity College London

Winston Wing ShingFung Chair Hong Kong, ChinaPrince of Wales Hospital, Hong Kong

What Have We Learned From CONVINCE?

HIT2-1

PeterBlankestijn Oral Abstract Presenter NetherlandsUniversity Medical Center Utrecht
Design of the ZEUS Trial: Interleukin-6 Inhibition With Ziltivekimab for Cardiovascular Protection in Chronic Kidney Disease

HIT2-2

VladoPerkovic Oral Abstract Presenter AustraliaUniversity of New South Wales, Sydney, Australia
A Phase 1/2 Trial of Zigakibart in IgA Nephropathy (IgAN)

HIT2-3

Jonathan Barret Oral Abstract Presenter jb81@leicester.ac.ukUnited KingdomUniversity of Leicester, Leicester, UK
Observational Cohort With Embedded Randomized Controlled Trials to Study Pregnancy-Associated Progression of Renal Disease: A Feasibility Study of Dietary Nitrate (Beetroot Juice) to Protect Kidney Function in Pregnant Women With Chronic Kidney Disease

HIT2-4

KateBramham Oral Abstract Presenter United KingdomKing's College London
Design of Randomized Embedded Adaptive Platform Clinical Trial in South Asian Kidney Biopsy-Proven Primary Glomerular Diseases: Multi-Center, Multi-Arm and Multi-Stage

HIT2-5

Selvin Sundar RajMani Oral Abstract Presenter IndiaAssociate Professor in Nephrology, Christian Medical College, Vellore, India

SuceenaAlexander Oral Abstract Presenter IndiaChristian Medical College Vellore

Brahmkamal Hall - Plenary Hall